List of Studies ( Metabolite:GM3 36:1;O2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004287 | AN007128 | Lipidomic profiling of PILRAKO xMG in xenotransplant model after mouse microglia(mMg) depletion | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004230 | AN007042 | Effect of ATV:4D9 on Microglial Metabolism and FDG levels in mKate-TREM2/APP mouse model | Microglia | Mouse | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004217 | AN007016 | Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction | Cultured cells | Human | Metabolic disease | Harvard Medical School | LC-MS |
| ST004206 | AN006996 | Lipidomic Profiling of Sorted Microglia in GPR34-KO/APP-KI Mice Across 4, 8, 16, and 24 Months | Glial cells | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004205 | AN006993 | Lipidomic/Metabolomic Characterization of GPR34 KO, WT, TREM2 KO, and GPR34/TREM2 dKO iPSC1-derived microglia | Glial cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004167 | AN006918 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST004163 | AN006910 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Metabolic disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006910 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006716 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006716 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004058 | AN006710 | Targeted Lipid and Metabolite Profiling in ATP13A2 knockout (KO) in HAP1 cells | Cultured cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004058 | AN006710 | Targeted Lipid and Metabolite Profiling in ATP13A2 knockout (KO) in HAP1 cells | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Human | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Mouse | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST003769 | AN006188 | Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease | Brain | Human | Alzheimers disease | University of Melbourne | LC-MS |
| ST003737 | AN006135 | PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST003326 | AN005448 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003290 | AN005389 | High expression of oleoyl-ACP-hydrolase underpins life-threatening respiratory viral diseases | Lung | Mouse | Viral infection | Peter Doherty Institute for Infection and Immunity | LC-MS |
| ST002817 | AN004585 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002713 | AN004398 | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002243 | AN003662 | Lipidomics analysis of Friedreich's ataxia (FRDA) (part II) | Blood | Human | Friedreichs Ataxia | University of Pennsylvania | LC-MS |
| ST002162 | AN003542 | CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis | Eye tissue | Mouse | Eye disease | University of Utah - Metabolomics Core | LC-MS |
| ST002162 | AN003543 | CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis | Eye tissue | Mouse | Eye disease | University of Utah - Metabolomics Core | LC-MS |
| ST001888 | AN003060 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001637 | AN002678 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001477 | AN002453 | Lipidomics dataset of PTEN deletion-induced nerve regeneration mouse model | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST001272 | AN002112 | Growth cone memebrane and growth cone particulate lipidomics | Brain | Mouse | Eye disease | University of Miami | LC-MS |
